Metasubstituted thiazolidinones, their manufacture and use as a drug
申请人:Schulze Klaus Volker
公开号:US20070015759A1
公开(公告)日:2007-01-18
This invention involves thiazolidinone of general formula (I)
and its creation and use as inhibitors of polo like kinase (PLK) for the treatment of various diseases.
New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
申请人:Prien Olaf
公开号:US20070010565A1
公开(公告)日:2007-01-11
The invention relates to thiazolidones of general formula (I):
to their production and to their use as inhibitors of the polo-like kinase (Plk) for treating various diseases.
本发明涉及通式(I)的噻唑烷酮,以及它们的生产和用作极化样激酶(Plk)抑制剂治疗各种疾病。
Thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
申请人:Prien Olaf
公开号:US20070010566A1
公开(公告)日:2007-01-11
The invention relates to thiazolidones of general formula (I)
as welt as to their production and to their use as inhibitors of the polo-like kinase (Plk) for treating various diseases, as welt as to intermediate products for the production of the compounds according to the invention.
METASUBSTITUTED THIAZOLIDINONES, THEIR MANUFACTURE AND USE AS A DRUG
申请人:SCHULZE Klause
公开号:US20100048891A1
公开(公告)日:2010-02-25
Thiazolidinones of general formula (I)
production thereof and use as inhibitors of polo like kinase (PLK) for the treatment of various diseases.
通式为(I)的噻唑烷酮及其制备方法和用途,作为极化样激酶(PLK)抑制剂治疗各种疾病。
Substituierte Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel
申请人:Bayer Schering Pharma Aktiengesellschaft
公开号:EP2141163A1
公开(公告)日:2010-01-06
Die Erfindung betrifft Thiazolidinone der allgemeinen Formel ( I )
wobei R1, Q und X in den Ansprüchen definiert sind, deren Herstellung und Verwendung als Inhibitoren der Polo Like Kinase (Plk) zur Behandlung verschiedener Erkrankungen, sowie Zwischenprodukte zu deren Herstellung.
本发明涉及通式 ( I ) 的噻唑烷酮化合物
其中 R1、Q 和 X 在权利要求中定义,它们的制备和用作治疗各种疾病的类 polo 激酶(Plk)抑制剂,以及制备它们的中间体。